相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease
Angelique Camilleri et al.
CNS NEUROSCIENCE & THERAPEUTICS (2014)
α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?
Aoife P. Kiely et al.
ACTA NEUROPATHOLOGICA (2013)
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease
Jens Wagner et al.
ACTA NEUROPATHOLOGICA (2013)
Gallic acid provokes DNA damage and suppresses DNA repair gene expression in human prostate cancer PC-3 cells
Kuo-Ching Liu et al.
ENVIRONMENTAL TOXICOLOGY (2013)
Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment
Jason R. Cannon et al.
EXPERIMENTAL NEUROLOGY (2013)
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
Silke Appel-Cresswell et al.
MOVEMENT DISORDERS (2013)
Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activity
Hsieh-Hsun Ho et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Natural polyphenols against neurodegenerative disorders: Potentials and pitfalls
Azadeh Ebrahimi et al.
AGEING RESEARCH REVIEWS (2012)
Insights into Mitochondrial Dysfunction: Aging, Amyloid-β, and Tau-A Deleterious Trio
Karen Schmitt et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Dihydroxybenzoic Acid Isomers Differentially Dissociate Soluble Biotinyl-Aβ(1-42) Oligomers
Harry LeVine et al.
BIOCHEMISTRY (2012)
α-Synuclein misfolding and Parkinson's disease
Leonid Breydo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
The Amyloid Beta Peptide: A Chemist's Perspective. Role in Alzheimer's and Fibrillization
I. W. Hamley
CHEMICAL REVIEWS (2012)
α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer
Bruno Fauvet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Accumulation of Toxic α-Synuclein Oligomer within Endoplasmic Reticulum Occurs in α-Synucleinopathy In Vivo
Emanuela Colla et al.
JOURNAL OF NEUROSCIENCE (2012)
Protective Effects of the Key Compounds Isolated from Corni fructus against β-Amyloid-Induced Neurotoxicity in PC12 Cells
Seung-Young Hong et al.
MOLECULES (2012)
Increased dimerization of alpha-synuclein in erythrocytes in Gaucher disease and aging
Assimina Argyriou et al.
NEUROSCIENCE LETTERS (2012)
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Kelvin C. Luk et al.
SCIENCE (2012)
Mitochondrial Biology and Parkinson's Disease
Celine Perier et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
α-Synuclein in Parkinson's Disease
Leonidas Stefanis
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds
Mario Caruana et al.
FEBS LETTERS (2011)
Pathological roles of α-synuclein in neurological disorders (vol 10, pg 1015, 2011)
K. Vekrellis et al.
LANCET NEUROLOGY (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
Cognitive dysfunctions induced by a cholinergic blockade and Aβ25-35 peptide are attenuated by salvianolic acid B
Dong Hyun Kim et al.
NEUROPHARMACOLOGY (2011)
Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection
Jennifer Hui-Chun Ho et al.
JOURNAL OF BIOMEDICAL SCIENCE (2011)
Pathological roles of α-synuclein in neurological disorders
Kostas Vekrellis et al.
LANCET NEUROLOGY (2011)
Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity
Saviana Di Giovanni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Targeting insulin amyloid assembly by small aromatic molecules Toward rational design of aggregation inhibitors
Michal Levy-Sakin et al.
ISLETS (2009)
Neuroprotective properties of gallic acid from Sanguisorbae radix on amyloid beta protein (25-35)-induced toxicity in cultured rat cortical neurons
Ju Yeon Ban et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
alpha-Synuclein Misfolding and Neurodegenerative Diseases
Vladimir N. Uversky
CURRENT PROTEIN & PEPTIDE SCIENCE (2008)
Protein aggregation in the brain: The molecular basis for Alzheimer's and Parkinson's diseases
G. Brent Irvine et al.
MOLECULAR MEDICINE (2008)
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E. Ehrnhoefer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
alpha-synucleinopathy models and human neuropathology: similarities and differences
Philipp J. Kahle
ACTA NEUROPATHOLOGICA (2008)
Mitochondrial dysfunction:: The first domino in brain aging and Alzheimer's disease?
Kristina Leuner et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: Influence of linker length and flexibility
Ashley A. Reinke et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2007)
Antimelanogenic and antioxidant properties of gallic acid
You-Jung Kim
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
SUMO on the road to neurodegeneration
Veronique Dorval et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
The aggregation and fibrillation of α-synuclein
Anthony L. Fink
ACCOUNTS OF CHEMICAL RESEARCH (2006)
Small molecule inhibitors of α-synuclein filament assembly
Masami Masuda et al.
BIOCHEMISTRY (2006)
Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for α-synuclein fibrils in vitro
K Ono et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity
S Bastianetto et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism
Y Porat et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Characterization of oligomeric intermediates in α-synuclein fibrillation:: FRET studies of Y125W/Y133F/Y136F α-synuclein
J Kaylor et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins
S Taniguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The E46K mutation in α-synuclein increases amyloid fibril formation
EA Greenbaum et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo
FS Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Causal relation between α-synuclein gene duplication and familial Parkinson's disease
P Ibáñez et al.
LANCET (2004)
The flavonoid baicalein inhibits fibrillation of α-synuclein and disaggregates existing fibrils
M Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
A structural and functional role for 11-mer repeats in α-synuclein and other exchangeable lipid binding proteins
R Bussell et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Biomedicine - Toxic proteins in neurodegenerative disease
JP Taylor et al.
SCIENCE (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Human α-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine
E Junn et al.
NEUROSCIENCE LETTERS (2002)
Selective insolubility of α-Synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model
PJ Kahle et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Fluorescence anisotropy:: A method for early detection of Alzheimer β-peptide (Aβ) aggregation
D Allsop et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils
OMA El-Agnaf et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Conformational properties of α-synuclein in its free and lipid-associated states
D Eliezer et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Three key residues form a critical contact network in a protein folding transition state
M Vendruscolo et al.
NATURE (2001)
Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
LC Serpell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A Drosophila model of Parkinson's disease
MB Feany et al.
NATURE (2000)
Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid
KA Conway et al.
BIOCHEMISTRY (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Mechanisms of inhibition of carcinogenesis by tea
CS Yang et al.
BIOFACTORS (2000)
分享论文
